ArticleJournal of molecular and cellular cardiology plus2026
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.
Anna Cinkajzlova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.